Trials / Completed
CompletedNCT06368479
Diagnostic Sensitivity and Specificity of iStatis HBsAg Test at the Point-Of-Care Site Settings
A Prospective Cross-Sectional Study to Evaluate Diagnostic Sensitivity and Specificity of iStatis HBsAg Test at the Point-Of-Care Site Settings
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 1,400 (actual)
- Sponsor
- bioLytical Laboratories · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
A prospective cross-sectional study in which surgically non-invasive sample-taking is done only for the purpose of testing the samples on iStatis HBsAg Test at the point of care.
Detailed description
Participants are prospctively recruited and enrolled to participate in the study. The Capillary (fingerstick) whole blood, and venous whole blood samples (in serum separating tube (SST) and Ethylenediaminetetraacetic acid (EDTA) tube) are collected by a healthcare professional. Serum and plasma samples will be extracted through laboratory processing of the collected serum separating tube and Ethylenediaminetetraacetic acid VWB, respectively. The collected samples of capillary will be tested on iStatis HBsAg Test. The collected Ethylenediaminetetraacetic acid and serum separating tube VWB will be shipped to the central laboratory to appropriately process and extract serum and plasma samples. Ethylenediaminetetraacetic acid VWB, plasma and serum will be tested on iStatis HBsAg Test in the laboratory. An aliquot of the obtained plasma sample will be further tested for reference and confirmatory testing. The results from iStatis HBsAg Test results will not be used for participant management decisions.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | iStatis HBsAg Test | Capillary (fingerstick) blood, EDTA venous whole blood, serum and plasma samples to be tested on the iStatis HBsAg Test at the point of care setting. |
Timeline
- Start date
- 2024-03-19
- Primary completion
- 2024-07-19
- Completion
- 2024-07-19
- First posted
- 2024-04-16
- Last updated
- 2025-02-21
Locations
1 site across 1 country: South Africa
Source: ClinicalTrials.gov record NCT06368479. Inclusion in this directory is not an endorsement.